Advertisement
Screener

Loxo Oncology, Inc. Stock-Based Compensation

Loxo Oncology, Inc. Stock-Based Compensation

Loxo Oncology, Inc. reported Stock-Based Compensation of $33.15 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2018-11-08

  • Loxo Oncology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2018-09-30 was $11.15M, a 111.75% increase year-over-year.
  • Loxo Oncology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2018-06-30 was $12.35M, a 127.12% increase year-over-year.
  • Loxo Oncology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2018-03-31 was $9.65M, a 142.85% increase year-over-year.
  • Loxo Oncology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2017-12-31 was $4.75M, a 84.92% increase year-over-year.
  • Loxo Oncology, Inc. share-based payment arrangement, noncash expense for fiscal 2017 was $19.42M, a 143.99% increase from fiscal 2016.
  • Loxo Oncology, Inc. share-based payment arrangement, noncash expense for fiscal 2016 was $7.96M, a 29.35% increase from fiscal 2015.
  • Loxo Oncology, Inc. share-based payment arrangement, noncash expense for fiscal 2015 was $6.15M, a 101.84% increase from fiscal 2014.
  • Loxo Oncology, Inc. share-based payment arrangement, noncash expense for fiscal 2014 was $3.05M.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 8 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2018-09-30$11.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$23.50M
derived: sum of 2 quarters · filed 2018-11-08
$33.15M
10-Q · filed 2018-11-08
$37.90M
derived: sum of 4 quarters · filed 2018-11-08
2018-06-30$12.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$22.00M
10-Q · filed 2018-08-09
$26.74M
derived: sum of 3 quarters · filed 2018-08-09
$32.01M
derived: sum of 4 quarters · filed 2018-11-08
2018-03-31$9.65M
10-Q · filed 2018-05-08
$14.40M
derived: sum of 2 quarters · filed 2018-05-08
$19.66M
derived: sum of 3 quarters · filed 2018-11-08
$25.10M
derived: sum of 4 quarters · filed 2018-11-08
2017-12-31$4.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$10.01M
derived: sum of 2 quarters · filed 2018-11-08
$15.45M
derived: sum of 3 quarters · filed 2018-11-08
$19.42M
10-K · filed 2018-03-01
2017-09-30$5.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$10.70M
derived: sum of 2 quarters · filed 2018-11-08
$14.68M
10-Q · filed 2018-11-08
$17.24M
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30$5.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$9.41M
10-Q · filed 2018-08-09
$11.98M
derived: sum of 3 quarters · filed 2018-08-09
$14.74M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$3.97M
10-Q · filed 2018-05-08
$6.54M
derived: sum of 2 quarters · filed 2018-05-08
$9.30M
derived: sum of 3 quarters · filed 2018-05-08
$10.59M
derived: sum of 4 quarters · filed 2018-05-08
2016-12-31$2.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$5.33M
derived: sum of 2 quarters · filed 2018-03-01
$6.62M
derived: sum of 3 quarters · filed 2018-03-01
$7.96M
10-K · filed 2018-03-01
2016-09-30$2.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
$4.05M
derived: sum of 2 quarters · filed 2017-11-02
$5.39M
10-Q · filed 2017-11-02
$7.70M
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30$1.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$2.63M
10-Q · filed 2017-08-08
$4.93M
derived: sum of 3 quarters · filed 2018-03-01
$6.10M
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31$1.34M
10-Q · filed 2017-05-09
$3.65M
derived: sum of 2 quarters · filed 2018-03-01
$4.81M
derived: sum of 3 quarters · filed 2018-03-01
$6.45M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$2.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$3.47M
derived: sum of 2 quarters · filed 2018-03-01
$5.11M
derived: sum of 3 quarters · filed 2018-03-01
$6.15M
10-K · filed 2018-03-01
2015-09-30$1.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$2.80M
derived: sum of 2 quarters · filed 2016-11-02
$3.85M
10-Q · filed 2016-11-02
$4.33M
derived: sum of 4 quarters · filed 2017-03-07
2015-06-30$1.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
$2.68M
10-Q · filed 2016-08-03
$3.16M
derived: sum of 3 quarters · filed 2017-03-07
$5.20M
derived: sum of 4 quarters · filed 2017-03-07
2015-03-31$1.05M
10-Q · filed 2016-05-04
$1.53M
derived: sum of 2 quarters · filed 2017-03-07
$3.56M
derived: sum of 3 quarters · filed 2017-03-07
$4.03M
derived: sum of 4 quarters · filed 2017-03-07
2014-12-31$477.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07
$2.51M
derived: sum of 2 quarters · filed 2017-03-07
$2.98M
derived: sum of 3 quarters · filed 2017-03-07
$3.05M
10-K · filed 2017-03-07
2014-09-30$2.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10
$2.51M
derived: sum of 2 quarters · filed 2015-11-10
$2.57M
10-Q · filed 2015-11-10
2014-06-30$473.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
$537.00K
10-Q · filed 2015-08-05
2014-03-31$64.00K
10-Q · filed 2015-05-14
2013-12-31$70.00K
10-K · filed 2015-03-27